Align Technology, Inc. ( ALGN ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:30 AM EST Company Participants John Morici - CFO & Executive VP of Global Finance Joseph Hogan - President, CEO & Director Presentation Unknown Analyst I'm an analyst on the U.S. Medical Supplies and Devices team, and this is a session for Align Technology. From the company, we've got Joe Hogan, President and CEO; John Morici, CFO; and we've also got Shirley Stacy here as well.
Align Technology, Inc. ( ALGN ) UBS Global Healthcare Conference 2025 November 11, 2025 11:45 AM EST Company Participants John Morici - CFO & Executive VP of Global Finance Conference Call Participants Kevin Caliendo - UBS Investment Bank, Research Division Presentation Kevin Caliendo UBS Investment Bank, Research Division Good afternoon, everybody. I'm Kevin Caliendo, Healthcare IT distribution, Dental Analyst for UBS.
Expedia's bookings growth accelerated based on strength in its business-to-business activities, and management raised its outlook. Despite reporting better results, FMC's share price was weak. Pinnacle Financial lagged after announcing an all-stock acquisition of a rival company.
Align Technology jumps 15% after Q3 earnings and revenues beat estimates, though steep margin declines weigh on results.
Align Technology, Inc. ( ALGN ) Q3 2025 Earnings Call October 29, 2025 4:30 PM EDT Company Participants Shirley Stacy - Vice President of Corporate Communications & Investor Relations Joseph Hogan - President, CEO & Director John Morici - CFO & Executive VP of Global Finance Conference Call Participants Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Michael Cherny - Leerink Partners LLC, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Brandon Vazquez - William Blair & Company L.L.C.
Shares of Align Technology (ALGN) are up 0.30% today, but the real action is happening off the tape.
Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Align Technology readies its Q3 report, with steady Clear Aligner demand and scanner upgrades expected to shape its performance.
Align Technology, Inc. (NASDAQ:ALGN ) Baird Global Healthcare Conference 2025 September 10, 2025 11:25 AM EDT Company Participants John Morici - CFO & Executive VP of Global Finance Shirley Stacy - Vice President of Corporate Communications & Investor Relations Conference Call Participants Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Presentation Jeffrey Johnson Senior Research Analyst All right.
Align Technology, Inc. (NASDAQ:ALGN ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:00 AM EDT Company Participants John Morici - CFO & Executive VP of Global Finance Shirley Stacy - Vice President of Corporate Communications & Investor Relations Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Hi. Good morning, everyone.
Align Technology, Inc. (NASDAQ:ALGN ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 10:15 AM EDT Company Participants John Morici - CFO & Executive VP of Global Finance Shirley Stacy - Vice President of Corporate Communications & Investor Relations Conference Call Participants Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Presentation Vikramjeet Chopra Associate Equity Analyst Okay. Good morning, everyone.
ALGN's Q2 results disappointed, with revenue and earnings misses and guidance for sequential declines, prompting major restructuring and cautious sentiment. Long-term positives include digital workflow/AI advancements, iTero ecosystem growth, and emerging market momentum, but clear aligner volume stagnation and macro headwinds persist. Despite a strong balance sheet and share buybacks, ALGN trades at a premium for its growth, and sentiment remains neutral-to-bearish, warranting patience and vigilance.